CRE-Enhancer DNA Decoy
- 1 December 2003
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1002 (1) , 124-133
- https://doi.org/10.1196/annals.1281.011
Abstract
Enhancer DNA decoy oligonucleotides (ODNs) inhibit transcription by competing for transcription factors. A decoy ODN composed of the cAMP response element (CRE) inhibits CRE-directed gene transcription and tumor growth without affecting normal cell growth. We used DNA microarrays to analyze the global gene expression in tumors exposed to the CRE-decoy ODN. The CRE decoy upregulated the AP-2beta transcription factor gene in tumors but not in the livers of host animals. The upregulated expression of AP-2beta was clustered with other upregulated genes involved in development and cell differentiation. Concomitantly, another cluster of genes involved in cell proliferation and transformation was downregulated. The observed alterations indicate that CRE-directed transcription favors tumor growth. Evidence presented here suggests that the CRE-decoy ODN may provide a target-based genetic tool for treating cancer, viral diseases, and other diseases in which CRE-directed transcription is abnormally used.Keywords
This publication has 38 references indexed in Scilit:
- Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: protein kinase A downregulation and cytoplasmic export of CRE-binding proteins.Molecular and Cellular Biochemistry, 2001
- Dual Blockade of Cyclic AMP Response Element- (CRE) and AP-1-directed Transcription by CRE-transcription Factor Decoy OligonucleotidePublished by Elsevier ,1999
- Antisense therapeuticsCurrent Opinion in Chemical Biology, 1998
- Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studiesProceedings of the National Academy of Sciences, 1997
- A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.Proceedings of the National Academy of Sciences, 1995
- Regulation of Gene Expression with Double-Stranded Phosphorothioate OligonucleotidesScience, 1990
- Oligonucleotide Analogues as Potential Chemotherapeutic AgentsPharmaceutical Research, 1988
- Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin geneNature, 1987
- Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cellsCell, 1987
- The inducible Iac operator-repressor system is functional in mammalian cellsCell, 1987